FDA Brief

Warning letters Drugs

FDA warning letter to

Elevate Your Wellness LLC, dba Elevated

LowIssued Sep 9, 2025Posted Sep 16, 2025Center for Drug Evaluation and Research (CDER)

FDA warned Elevated that its website offered compounded semaglutide and tirzepatide with misleading claims they match FDA-approved drugs.

What happened

In August 2025, FDA reviewed website content at https://elevatedhealth.com and observed that the site offered compounded drug products, including semaglutide and tirzepatide. FDA said website claims implied the compounded products were the same as FDA-approved drugs, although compounded drugs are not FDA-approved. The letter cites claims about 'personalized versions' and 'same active ingredient,' including for Semaglutide ODT.

What FDA found

  1. FDA said the website claims for compounded semaglutide and tirzepatide were false or misleading, making the drugs misbranded (mislabeled in a way that violates federal law).

    FDCA section 502(a) [21 U.S.C. § 352(a)]
  2. FDA said advertising or promotion for the compounded drugs was false or misleading, making the drugs misbranded.

    FDCA section 502(bb) [21 U.S.C. § 352(bb)]
  3. FDA said the misbranded drugs were introduced or delivered for introduction into interstate commerce.

    FDCA section 301(a) [21 U.S.C. § 331(a)]
  4. FDA said receiving, delivering, or offering to deliver misbranded drugs in interstate commerce is also prohibited.

    FDCA section 301(c) [21 U.S.C. § 331(c)]

What FDA wants

Within 15 working days of receipt, provide a written response to CDER's Office of Compounding Quality and Compliance describing steps taken to address the violations and prevent recurrence, with related documentation; include reasoning if you believe the products are not in violation.

Who should pay attention

  • telehealth companies selling compounded GLP-1 drugs
  • compounding pharmacies and their marketing partners
  • brands making comparison claims to FDA-approved drugs

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low